# TAXUS PERSEUS Workhorse

> **NCT00484315** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 1264 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation
- **DEVICE:** Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Express) placement

## Key facts

- **NCT ID:** NCT00484315
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-09
- **Final completion:** 2013-10
- **Target enrollment:** 1264 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484315, "TAXUS PERSEUS Workhorse". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00484315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*